Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Ingevity (NGVT) EBT (2016 - 2025)

Historic EBT for Ingevity (NGVT) over the last 11 years, with Q3 2025 value amounting to $62.2 million.

  • Ingevity's EBT rose 1518.52% to $62.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$424.7 million, marking a year-over-year increase of 1615.0%. This contributed to the annual value of -$535.6 million for FY2024, which is 520297.03% down from last year.
  • According to the latest figures from Q3 2025, Ingevity's EBT is $62.2 million, which was up 1518.52% from -$142.7 million recorded in Q2 2025.
  • In the past 5 years, Ingevity's EBT ranged from a high of $95.8 million in Q3 2022 and a low of -$371.0 million during Q4 2024
  • For the 5-year period, Ingevity's EBT averaged around -$18.7 million, with its median value being $36.3 million (2021).
  • Per our database at Business Quant, Ingevity's EBT skyrocketed by 116444.44% in 2022 and then crashed by 88172.59% in 2023.
  • Ingevity's EBT (Quarter) stood at $36.3 million in 2021, then crashed by 45.73% to $19.7 million in 2022, then plummeted by 881.73% to -$154.0 million in 2023, then plummeted by 140.91% to -$371.0 million in 2024, then skyrocketed by 116.77% to $62.2 million in 2025.
  • Its EBT stands at $62.2 million for Q3 2025, versus -$142.7 million for Q2 2025 and $26.8 million for Q1 2025.